Senseonics Holdings, Inc. (SENS)
NYSEAMERICAN: SENS · IEX Real-Time Price · USD
0.466
+0.014 (3.10%)
At close: Jul 19, 2024, 4:00 PM
0.470
+0.004 (0.88%)
Pre-market: Jul 22, 2024, 7:07 AM EDT
Senseonics Holdings Revenue
Senseonics Holdings had revenue of $23.30M in the twelve months ending March 31, 2024, with 29.13% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.05M with 22.00% year-over-year growth. In the year 2023, Senseonics Holdings had annual revenue of $22.39M with 36.62% growth.
Revenue (ttm)
$23.30M
Revenue Growth
+29.13%
P/S Ratio
10.62
Revenue / Employee
$176,515
Employees
132
Market Cap
247.39M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 22.39M | 6.00M | 36.62% |
Dec 31, 2022 | 16.39M | 2.71M | 19.85% |
Dec 31, 2021 | 13.68M | 8.73M | 176.32% |
Dec 31, 2020 | 4.95M | -16.35M | -76.77% |
Dec 31, 2019 | 21.30M | 2.39M | 12.63% |
Dec 31, 2018 | 18.91M | 12.54M | 196.77% |
Dec 31, 2017 | 6.37M | 6.04M | 1,819.58% |
Dec 31, 2016 | 332.00K | 294.00K | 773.68% |
Dec 31, 2015 | 38.00K | - | - |
Dec 31, 2014 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Codexis | 74.23M |
AVITA Medical | 51.50M |
Utah Medical Products | 49.04M |
Zevra Therapeutics | 28.01M |
Profound Medical | 5.33M |
Immutep | 4.58M |
Cibus | 2.32M |
Atai Life Sciences | 277.00K |
SENS News
- 4 weeks ago - Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook - Business Wire
- 5 weeks ago - Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association's 84th Scientific Sessions - Business Wire
- 7 weeks ago - Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference - Business Wire
- 2 months ago - Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results - Business Wire
- 2 months ago - Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management - Business Wire
- 2 months ago - Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution - Business Wire
- 2 months ago - Senseonics Holdings, Inc. to Participate in Upcoming Conferences - Business Wire
- 2 months ago - Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time - Business Wire